Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Expert Q&A: A Drug Holiday for Metastatic Prostate Cancer?

2.

Ivonescimab Tops Pembrolizumab in PD-L1-Positive, Advanced NSCLC

3.

Weight loss trial reports success for breast cancer patients at one year mark

4.

Tissue-Free ctDNA Strongly Prognostic of Recurrence in TNBC

5.

Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot